Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?
Standard
Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model? / Deuse, Tobias; Schrepfer, Sonja; Reichenspurner, Hermann; Hoyt, Grant; Fischbein, Michael P; Robbins, Robert C; Pelletier, Marc P.
in: TRANSPL IMMUNOL, Jahrgang 17, Nr. 4, 06.2007, S. 255-261.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?
AU - Deuse, Tobias
AU - Schrepfer, Sonja
AU - Reichenspurner, Hermann
AU - Hoyt, Grant
AU - Fischbein, Michael P
AU - Robbins, Robert C
AU - Pelletier, Marc P
PY - 2007/6
Y1 - 2007/6
N2 - BACKGROUND: Different animal models have been developed to study the pathogenesis and treatment of obliterative airway disease (OAD). Here we describe the techniques of heterotopic and orthotopic tracheal transplantations in the rat, comparing the kinetics of systemic host immune response and of histopathologic OAD development.METHODS: Heterotopic and orthotopic tracheal transplantations were performed in both allogeneic (Brown Norway-to-Lewis) and syngeneic (Lewis-to-Lewis) models. Grafts were harvested after 7, 30, and 60 days post-transplant for histologic evaluation and analysis of host cellular and humoral response.RESULTS: Syngeneic tracheal grafts did not develop luminal obliteration and were morphologically indistinguishable from native tracheas. In heterotopic allografts, airway epithelium was rapidly destroyed and OAD progressed with complete luminal occlusion by 30 days. Orthotopic allografts showed enhanced early infiltration (1298+/-45 vs. 674+/-75 cells/high power field, p<0.001) with concomitant greater day 7 luminal narrowing (45+/-6% vs. 14+/-3%, p<0.001). In this model, donor-type BN epithelium (62+/-17%, 21+/-19%, and 1+/-1% on days 7, 30, and 60) was gradually replaced by recipient-type epithelial cells (2+/-4%, 70+/-22%, and 98+/-2%). OAD developed with circular orientation of cells and connective tissue fibers to 45+/-6% obliteration by day 60. Cellular host response, as determined by IFN-gamma-ELISPOT assay (548+/-132 vs. 402+/-197 spots, p=0.046) and anti-donor alloreactive IgM antibody production (2827+/-148 vs. 1565+/-393 mean channel fluorescence, p<0.001) were significantly stronger in rats bearing orthotopic vs. heterotopic allografts.CONCLUSIONS: The orthotopic tracheal transplantation model may be more representative of OAD found in human lung transplant recipients and we therefore encourage the wider use of this model.
AB - BACKGROUND: Different animal models have been developed to study the pathogenesis and treatment of obliterative airway disease (OAD). Here we describe the techniques of heterotopic and orthotopic tracheal transplantations in the rat, comparing the kinetics of systemic host immune response and of histopathologic OAD development.METHODS: Heterotopic and orthotopic tracheal transplantations were performed in both allogeneic (Brown Norway-to-Lewis) and syngeneic (Lewis-to-Lewis) models. Grafts were harvested after 7, 30, and 60 days post-transplant for histologic evaluation and analysis of host cellular and humoral response.RESULTS: Syngeneic tracheal grafts did not develop luminal obliteration and were morphologically indistinguishable from native tracheas. In heterotopic allografts, airway epithelium was rapidly destroyed and OAD progressed with complete luminal occlusion by 30 days. Orthotopic allografts showed enhanced early infiltration (1298+/-45 vs. 674+/-75 cells/high power field, p<0.001) with concomitant greater day 7 luminal narrowing (45+/-6% vs. 14+/-3%, p<0.001). In this model, donor-type BN epithelium (62+/-17%, 21+/-19%, and 1+/-1% on days 7, 30, and 60) was gradually replaced by recipient-type epithelial cells (2+/-4%, 70+/-22%, and 98+/-2%). OAD developed with circular orientation of cells and connective tissue fibers to 45+/-6% obliteration by day 60. Cellular host response, as determined by IFN-gamma-ELISPOT assay (548+/-132 vs. 402+/-197 spots, p=0.046) and anti-donor alloreactive IgM antibody production (2827+/-148 vs. 1565+/-393 mean channel fluorescence, p<0.001) were significantly stronger in rats bearing orthotopic vs. heterotopic allografts.CONCLUSIONS: The orthotopic tracheal transplantation model may be more representative of OAD found in human lung transplant recipients and we therefore encourage the wider use of this model.
KW - Animals
KW - Antibody Formation
KW - Disease Models, Animal
KW - Epithelial Cells/immunology
KW - Male
KW - Organ Transplantation/methods
KW - Pulmonary Disease, Chronic Obstructive/immunology
KW - Rats
KW - Rats, Inbred Strains
KW - Trachea/immunology
KW - Transplants
U2 - 10.1016/j.trim.2007.01.009
DO - 10.1016/j.trim.2007.01.009
M3 - SCORING: Journal article
C2 - 17493528
VL - 17
SP - 255
EP - 261
JO - TRANSPL IMMUNOL
JF - TRANSPL IMMUNOL
SN - 0966-3274
IS - 4
ER -